Veracyte's better-than-expected Q4 2023 earnings and sales figures, especially the substantial year-over-year sales growth, are likely to positively impact investor sentiment and the stock price in the short term. The significant beat on both the top and bottom lines indicates operational efficiency and growing demand for the company's offerings, which could lead to increased investor confidence and potential stock price appreciation.